Markets:

Overview

News

Currencies

International

Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

23.22 -0.23 (-0.98%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

3 Russell 2000 Stocks with Warning Signs

November 16, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

5 Revealing Analyst Questions From Privia Health’s Q3 Earnings Call

November 13, 2025

Privia Health’s third quarter results surpassed Wall Street’s expectations, yet the market responded negatively—a reaction management attributed in part to uncertainties surrounding the sustainability...

Via StockStory

Topics Earnings

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest

November 11, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with Hims...

Via StockStory

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

PRVA Q3 Deep Dive: Acquisition and Value-Based Care Expansion Shape Outlook

November 07, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year...

Via StockStory

Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q3 2025 Results, Raises Full-Year Guidance ↗

November 06, 2025

Privia Health's Q3 2025 earnings beat on EPS and raised full-year guidance, driving a positive market reaction despite a revenue miss.

Via Chartmill

Topics Earnings

Privia Health (NASDAQ:PRVA) Surprises With Strong Q3

November 06, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year revenue...

Via StockStory

Privia Health (PRVA) To Report Earnings Tomorrow: Here Is What To Expect

November 04, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results this Thursday before market hours. Here’s what investors should know.

Via StockStory

1 Profitable Stock on Our Buy List and 2 We Question

October 31, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

October 20, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,...

Via StockStory

3 Overrated Stocks That Fall Short

October 20, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

October 06, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology industry, including GoodRx (NASDAQ:GDRX) and its peers.

Via StockStory

3 Cash-Heavy Stocks We Keep Off Our Radar

October 03, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care ↗

September 24, 2025

Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.

Via Benzinga

What 5 Analyst Ratings Have To Say About Privia Health Gr ↗

September 24, 2025

Via Benzinga

1 Russell 2000 Stock to Consider Right Now and 2 We Brush Off

September 23, 2025

Via StockStory

1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds

September 17, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Winners And Losers Of Q2: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Healthcare Technology for Providers Stocks

September 14, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health...

Via StockStory

Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy

Breaking Down Privia Health Gr: 4 Analysts Share Their Views ↗

September 04, 2025

Via Benzinga

Why Is Privia Health (PRVA) Stock Soaring Today

August 29, 2025

Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 6.4% in the morning session after the company announced its Accountable Care Organizations (ACOs) achieved $233.1 million in...

Via StockStory

Topics Initial Public Offering Lawsuit

Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks

August 27, 2025

Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers.

Via StockStory

3 Cash-Producing Stocks We Think Twice About

August 22, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS)

August 21, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology stocks, starting...

Via StockStory

PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance

August 12, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects...

Via StockStory

Beyond The Numbers: 4 Analysts Discuss Privia Health Gr Stock ↗

August 11, 2025

Via Benzinga

Privia Health (NASDAQ:PRVA) Reports Upbeat Q2

August 07, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects...

Via StockStory

Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q2 2025 Results, Raises Full-Year Guidance Despite Earnings Miss ↗

August 07, 2025

Privia Health (PRVA) reported mixed Q2 2025 results, missing revenue and EPS estimates but raising full-year guidance, sparking a 6.2% pre-market stock surge.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

Headline News about Privia Health Group, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today